Adam Grippin, MD, PhD

MD Anderson Cancer Center
Houston, TX

Adam Grippin completed his MD and his PhD in Biomedical Engineering at the University of Florida. He is a current resident in radiation oncology at the MD Anderson Cancer Center. His research focus includes cancer immunotherapy, nanotechnology, and CNS tumors.

Disclosures:

• Employment: MD Anderson Cancer Center:Resident:Employee
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 298 - IMMUNOCERV Phase II Trial Combining the HPV-Specific T Cell Immunotherapy PDS0101 with Chemoradiation for Treatment of Locally Advanced Cervical Cancer

  Tuesday, October 1, 2024
  2:50 PM – 3:00 PM ET

• 3654 - Multicenter Phase III Trial of Chemoradiation (CRT) with IMPT vs. IMRT for Oropharyngeal Squamous Cell Carcinoma (OPSCC): Secondary Analysis of Association of Lymphopenia with Treatment Modality, Emer

  Wednesday, October 2, 2024
  10:30 AM – 11:45 AM ET